Alejandra Boo-Comins

Santander, CB 39008, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Do Serologic Domains of the 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome Define Distinct Clinical Subgroups During Pregnancy?

Do Serologic Domains of the 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome Define Distinct Clinical Subgroups During Pregnancy?

Journal: International journal of molecular sciences

Published: June 05, 2026

Interval-specific likelihood ratios improve interpretation of antiphospholipid antibody testing across different analytical platforms.

Interval-specific likelihood ratios improve interpretation of antiphospholipid antibody testing across different analytical platforms.

Journal: Clinical chemistry and laboratory medicine

Published: June 01, 2026

The impact of antinuclear antibodies and complement levels in the prognosis of pregnant women within the antiphospholipid syndrome spectrum.

The impact of antinuclear antibodies and complement levels in the prognosis of pregnant women within the antiphospholipid syndrome spectrum.

Journal: Frontiers in immunology

Published: February 26, 2026

Impact of antiphospholipid and antinuclear antibodies in coronary artery disease progression.

Impact of antiphospholipid and antinuclear antibodies in coronary artery disease progression.

Journal: Frontiers in immunology

Published: May 21, 2025

Changes in NK Cells and Exhausted Th Cell Phenotype in RA Patients Treated with Janus Kinase Inhibitors: Implications for Adverse Effects.

Changes in NK Cells and Exhausted Th Cell Phenotype in RA Patients Treated with Janus Kinase Inhibitors: Implications for Adverse Effects.

Journal: International journal of molecular sciences

Published: March 28, 2025

Anti-Human Leukocyte Antigen Antibody Detection from Terasaki's Humoral Theory to Delisting Strategies in 2024.

Anti-Human Leukocyte Antigen Antibody Detection from Terasaki's Humoral Theory to Delisting Strategies in 2024.

Journal: International journal of molecular sciences

Published: December 05, 2024

Impact of the 2023 ACR/EULAR Classification Criteria in Women with Primary Antiphospholipid Syndrome during Pregnancy.

Impact of the 2023 ACR/EULAR Classification Criteria in Women with Primary Antiphospholipid Syndrome during Pregnancy.

Journal: Diagnostics (Basel, Switzerland)

Published: August 26, 2024

Allowable total error in CD34 cell analysis by flow cytometry based on state of the art using Spanish EQAS data.

Allowable total error in CD34 cell analysis by flow cytometry based on state of the art using Spanish EQAS data.

Journal: Clinical chemistry and laboratory medicine

Published: August 16, 2024

SARS-CoV-2 Infection and Liver Transplant: How Are We Now?

SARS-CoV-2 Infection and Liver Transplant: How Are We Now?

Journal: Transplantation proceedings

Published: August 14, 2024

Strategies for Moderate-risk Delisting in Highly Sensitized Patients.

Strategies for Moderate-risk Delisting in Highly Sensitized Patients.

Journal: Transplantation proceedings

Published: August 14, 2024

Are the new 2023 ACR/EULAR classification criteria suitable for advancing the knowledge of obstetric antiphospholipid syndrome?

Are the new 2023 ACR/EULAR classification criteria suitable for advancing the knowledge of obstetric antiphospholipid syndrome?

Journal: Autoimmunity reviews

Published: August 07, 2024

Non-HLA Antibodies and the Risk of Antibody-mediated Rejection without Donor-specific Anti-HLA Antibodies After Lung Transplantation.

Non-HLA Antibodies and the Risk of Antibody-mediated Rejection without Donor-specific Anti-HLA Antibodies After Lung Transplantation.

Journal: Transplantation proceedings

Published: August 01, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026